Infectious Disease

News on research and diagnostic development for pathogenic diseases.

FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

Azova's kit is for use with Fluidigm's Advanta Dx SARS-CoV-2 RT-PCR assay, an extraction-free, saliva-based COVID test that previously received EUA.

Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues

The company also said that it had received EUA from the US Food and Drug Administration for a non-prescription version of its COVID-19 sample collection kit.

OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval

The company's cartridge for pneumonia for the Unyvero system is under review and pending approval by Chinese regulators.

Hologic Acquires European MDx Firm Diagenode for Approximately $159M

Hologic said that the transaction further strengthens its molecular diagnostics business by expanding its international capabilities, among other benefits.

GenMark Diagnostics Seeing Continued Demand for Respiratory Panels, Plans 510(k) Submission

Premium

The firm said it is drawing up plans for its business in a post-pandemic world, planning the introduction of new testing panels and enhancing its respiratory panel.

Feb 25, 2021

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

Feb 25, 2021

Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch

Premium

Feb 25, 2021

German Nucleic Acid Sample Prep Startup Rides COVID-19 Testing, Automation Waves

Premium

Feb 25, 2021

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Feb 25, 2021

Biocartis Reports 15 Percent Rise in 2020 Revenues

Feb 25, 2021

Novacyt Obtains CE Mark for Extraction-Free COVID-19 PCR Test

Feb 24, 2021

Adaptive Biotechnologies Q4 Revenues Rise 25 Percent

Feb 24, 2021

BioMérieux Reports 21 Percent Revenue Growth in Q4

Feb 23, 2021

SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches

Feb 23, 2021

Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development

Feb 23, 2021

Adaptive Biotechnologies, LabCorp Expand Collaboration

Feb 23, 2021

Cue Health Nabs CE Mark for Molecular Point-of-Care COVID-19 Test

Feb 23, 2021

Meridian Withdraws Emergency Use Authorization Application to FDA for Coronavirus MDx Test

Feb 19, 2021

Qiagen Launches 'Digital Partner' Program to Expand Bioinformatics Reach

Feb 19, 2021

Thermo Fisher Scientific Sued by New Jersey Lab Over COVID-19 Testing Problems

Feb 19, 2021

Luminex Nabs $11.3M From BARDA to Develop Test for SARS-CoV-2, Flu, RSV

Feb 18, 2021

Quidel Q4 Revenues Increase Sharply on COVID-19 Sales, Beat EPS Estimates

Feb 18, 2021

WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance

Feb 18, 2021

Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO

Feb 18, 2021

FDA Grants EUAs for Direct-to-Consumer Coronavirus Sample Collection Kit, Two Molecular Tests

The Scan

More Details Wanted

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

And a Third

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Glimpses of Viral Origins

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.

Featured White Papers

Use of the LumiraDx SARS-CoV-2 Antigen Test in Pediatric Practice

Performance Evaluation of the LumiraDx SARS-CoV-2 Antigen Test to Aid Diagnosis of Acute COVID-19 at the Point of Care

An Evaluation of the Detection of SARS-CoV-2 Antigen in a Cohort of Symptomatic and Asymptomatic Patients: Report from the Evaluation of SKUP

Agena Bioscience’s SARS-CoV-2 Tests: Providing Resilience Against the Emergence of New Variants

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

17

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

18

Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Viruses mutate as they strive to thrive in response to selective pressures.

Mar

25

Featured Webinar

Virtual Molecular Tumor Board Series: What to Do with a ‘Negative’ Molecular Panel Case

In this session, the fourth in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling identified no clear molecular markers to help guide personalized therapy.

Menu

Infectious Disease

What's Popular?